September 2020 • PharmaTimes Magazine • 4-5
Jenny Ousbey, founder of OVID Health, on raising the bar for patient-centricity and findings from the 2020 Patient Partnership Index
John Pinching discusses with five panellists how pharma is successfully leveraging the experience and expertise of patient 2.0
Janssen's Joaquín Casariego says pharma can do more to ensure patients are truly front and centre
Roche’s Michael Goetzl looks at global variations in the approach to managing diabetes, and the potential lessons for the UK
Wilmington Healthcare's Oli Hudson explores how the coronavirus pandemic is changing pharma’s relationship with the NHS
Charlotte Walker-Osborn asks whether the law will be able to keep up
35.
Nick Warwick
Nick Warwick, chief medical officer at ADVANZ PHARMA, talks to PharmaTimes about his new role at the firm
40.
Appointments